NCT06619418

Brief Summary

Pain symptoms can have a variety of ways to be treated, from medications to physical therapy, with several options being available to patients. However, no one treatment may work for all people who experience pain, especially cLBP. The purpose of this study is to measure the compliance, usability, and satisfaction of an at-home, multi-modal stimulation device in a diverse population of people with chronic lower back pain (cLBP). The multi-modal device will include a combination of electrical stimulation, auditory stimulation, and integrative-health techniques, including mindfulness breathing, health coaching, and reflective journaling. The multi-modal device creation is based on prior knowledge in lower back pain treatment, which includes electrical stimulation of the back (Transcutaneous Electrical Nerve Stimulator or TENS) and integrative health modalities. In isolation, these treatments are only somewhat effective in reducing symptoms. This pilot study will involve participants who experience cLBP as we investigate a novel at-home, multi-modal device design. The main objective of the pilot usability study is to examine compliance to the intended use of the multi-modal device and approach, as well as protocol feasibility, and satisfaction with the settings and design.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
3mo left

Started Jul 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Jul 2024Aug 2026

Study Start

First participant enrolled

July 1, 2024

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

July 17, 2024

Completed
3 months until next milestone

First Posted

Study publicly available on registry

October 1, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 11, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 11, 2026

Last Updated

August 13, 2025

Status Verified

August 1, 2025

Enrollment Period

2.1 years

First QC Date

July 17, 2024

Last Update Submit

August 11, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • compliance rate

    Measure compliance in terms of time using the integrative health devices and the multi-modal stimulation device over a period of 12 weeks to determine the effect on participant compliance by adding electrical stimulation to the device.

    12 weeks

Secondary Outcomes (1)

  • satisfaction rate

    12 weeks

Study Arms (2)

device group

EXPERIMENTAL
Device: TENS device

Integrative health modality group

ACTIVE COMPARATOR
Behavioral: Integrative health modalities

Interventions

will be using an FDA- cleared TENS device for electrical stimulation (TENS 7000, Compass Health Brands) in combination with commercially-available headphones for acoustic stimulation (AKG 845 BT).Will be shown how to use the device, trained on the multimodal stimulation procedure, and sent home with the device for 12 weeks.

device group

will be instructed on the integrative health modalities for this study. They will be given a tablet that includes the videos for the visually guided deep breathing. They will also receive the reflective journal and be set up for health coaching visits. At the end of the 12 weeks, this group of participants will return to the U of M campus and complete an interview about satisfaction and usability of the IH modalities.

Integrative health modality group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Must be 18 years of age or older
  • Must be within commuting distance to the University of Minnesota
  • Able to provide consent and follow study instructions
  • Must be able to understand English
  • Must have chronic LBP, which is defined as lower back pain for more than 3 months
  • A score of 4 or higher on the PEG
  • Must be willing to commit to full duration of the study
  • Not currently taking any benzodiazepines or sedative hypnotics

You may not qualify if:

  • Back Pain associated with:
  • Spondylolisthesis or spinal stenosis
  • Sciatica or radiculopathy
  • Rhematologic or inflammatory disease
  • Trauma, fracture, dislocation, or previous back surgery
  • A score of 10 on the PEG
  • Pregnant
  • Have an electrically implanted device, such as a pacemaker.
  • Heart Disease
  • Epilepsy
  • Cancer
  • Psychiatric conditions including psychosis, suicidal ideation, or substance abuse disorder
  • A pure tone average of more than 40 dB HL at 500 dB, 1000 dB, or 2000 dB HL.
  • Individuals currently using other lower back pain treatments during the study in which they are unable to maintain a steady state while participating in our study for one month before beginning the multi-modal regimen.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Minnesota

Minneapolis, Minnesota, 55414, United States

RECRUITING

Study Officials

  • Molly Sturges

    University of Minnesota

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Grace Conchas

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 17, 2024

First Posted

October 1, 2024

Study Start

July 1, 2024

Primary Completion (Estimated)

August 11, 2026

Study Completion (Estimated)

August 11, 2026

Last Updated

August 13, 2025

Record last verified: 2025-08

Locations